Stakeholders Support Revision Of National Coverage Determination For Cardiac Pacemakers
This article was originally published in The Gray Sheet
Executive Summary
Stakeholders support the Heart Rhythm Society and the American College of Cardiology’s request that CMS update the 27-year-old clinical indications for group II, dual-chamber pacemakers.
You may also be interested in...
Cardiac Pacemaker National Medicare Coverage Policy Updated
CMS issued a final decision memo Aug. 13 to cover implantation of permanent single- and dual-chamber cardiac pacemakers for documented nonreversible symptomatic bradycardia due to sinus node dysfunction and second- and/or third-degree atrioventricular block.
Reimbursement In Brief
CMS proposes new indications for implanted cardiac pacemakers, declines coverage reconsideration request from Cyberonics. Trustees project Medicare solvency until 2026. More reimbursement briefs.
News In Brief
Physician sunshine rule finally released. CMS moves forward on bundled payment initiative. More news.